安进招聘

Company Introduction

Amgen in China

Amgen started to establish an affiliate in China since 2012, with the goal of making more of its innovative medicines available to patients in China. Over the years, Amgen has brought to the local market some of its advanced products through strategic

partnerships, and established its China headquarter in Shanghai after opening a representative office in Beijing. Besides, Amgen is conducting multiple clinical studies in China, planning to introduce more innovative medicines to Chinese patients to help them combat severe illnesses such as oncology and cardiovascular diseases.

Taking active part in Chinese government’s scheme of accelerating the development of innovative drugs and therapies, Amgen is at the forefront of improving the efficiency and speed of new drug introduction. With a strong foothold in China, Amgen proactively explores cooperation with leading domestic pharmaceutical companies, demonstrating its commitment to providing Chinese patients with innovative medicines and therapies. Driven by the commitment to act in the public interest and improve drug accessibility, we fully leverage our long-standing development and biologics manufacturing expertise to develop biosimilars. In September 2017, Amgen China announced a strategic collaboration with Simcere Pharmaceutical Group to co-develop and commercialize four biosimilars in the areas of inflammation and oncology. Leveraging Simcere’s capabilities in developing innovative pharmaceuticals and branded generic drugs, this partnership aims to accelerate the development and launch of high quality biosimilars in China.

Upholding its commitment to scientific excellence, Amgen places great importance on research and development and exploits its advantages in this area to the full, while continuously expanding external collaborations in China. In 2013, Amgen partnered with ShanghaiTech University to establish its Asia R&D Center on the campus. Inaugurated in 2014, Amgen Asia R&D Center was relocated to a new permanent lab in Zhangjiang Hi-Tech Park in March 2017, adjacent to top research institutes and prestigious universities. Amgen will continue to deepen its partnership with local research facilities, and advance the research and development of innovative medicines supported by top-quality clinical development and translational science research capabilities to better serve Chinese patients.

Clear Search
  • Salary
    • Work Time
      • Role Type
        • Full Time
        • Part Time
        • Intern
      • Location

      Available jobs

      Search